Startup aims to upend diabetes care with matchstick-size implant
Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.
Pharmaceutical
Articles
Target selling pharmacy, clinic businesses to CVS Health
Target Corp. has agreed to sell its pharmacy and clinic businesses to the drugstore chain CVS Health Corp. for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations.
Lilly to launch Lantus biosimilar in Europe in third quarter
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
Female libido drug nears approval with FDA panel’s backing
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
Indy’s Golden Age in 1920s shows way forward
In the 1920s, Indianapolis was one of the most innovative cities in the nation. But after “the dark tragedy of the roaring twenties,” Indianapolis lost its edginess for decades and only recently has begun to regain it.
Former Lilly partner set to pay $2.3B to settle Actos cases
Takeda Pharmaceutical Co. executives have agreed to pay more than $2.3 billion to resolve lawsuits accusing the company of hiding its Actos diabetes medicine’s cancer risks, three people familiar with the accord said.
Pence signs bill expanding use of overdose drug
The new law allows Indiana residents to obtain and use a drug that can reverse heroin overdoses in their relatives, friends and loved ones.
U.S. prescription drug spending jumps 13 percent
U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act.
Right-to-try drug bill signed into state law
Terminally ill patients in Indiana who have run out of FDA-approved options can now turn to treatments and medicines in the testing phase.
Potential Alzheimer’s drug further backs protein hypothesis
The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.
‘Right to try’ trial drugs bill heads to governor’s desk
A proposal to give terminally ill patients easier access to experimental drugs not yet on pharmacy shelves has been forwarded to Gov. Mike Pence for his signature.
Indiana Senate passes ‘right-to-try’ trial drugs bill
The Indiana Senate has approved a measure that would allow terminally ill patients to use experimental drugs that are not yet on pharmacy shelves.
Senate panel considers ‘right-to-try’ trial drugs bill
An Indiana Senate committee is considering a bill that would give terminally ill patients easier access to experimental drugs that have not received full federal approval. Indiana is one of nearly two dozen states that are considering the legislation.
Warnings ordered on testosterone drugs like Lilly’s Axiron
Makers of testosterone drugs must change the products’ labels to clarify that they are approved for only certain disorders, not to help men deal with aging, U.S. regulators said.
Bill aimed at reducing meth problems advances
The Indiana Senate passed a bill 46-3 on Tuesday that would make it more difficult for criminals to purchase products used in the production of meth.
Lilly to delay U.S., EU approval of basal insulin
Although the experimental diabetes drug is in final-stage testing and showing promising results, Lilly wants to better understand its effect on liver fat.
Feds finally end probe into Lilly bribery allegations
The U.S. Department of Justice told Lilly last month its investigation was over—more than a year after the drugmaker paid $29 million to the SEC to settle related bribery allegations.
Lawmakers aim to restrict access to meth ingredients
The leaders of Indiana communities hit hard by methamphetamine are arguing for a state law requiring prescriptions to buy cold and allergy pills.
How Eli Lilly CEO Lechleiter pulled company out of long slide
After weathering a barrage of patent expirations, the pharmaceutical giant has restocked its pipeline and is positioned to grow.
Medical-marijuana bill won’t fly this session, but attitudes shift
Indiana won’t put itself on the marijuana-friendly map this year, as a medical marijuana bill authored by Democratic Sen. Karen Tallian is unlikely to go further than a committee hearing.